Article
Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases.
Nucleic acids research - 15 Nov 2002
Hou Ming-Hon, Robinson Howard, Gao Yi-Gui, Wang Andrew H-J
Abstract excerpt
The potent anticancer drug actinomycin D (ActD) acts by binding to DNA GpC sequences, thereby interfering with essential biological processes including replication, transcription and topoisomerase. Certain neurological diseases are correlated with expansion of (CTG)n trinucleotide sequences, which contain many contiguous GpC sites separated by a single base pair. In order to characterize the binding of ActD to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
